0
Skip to Content
Biologic Eye Drops
Home
FAQ
FAQ
Report problems to the FDA
Report deceptive advertising
Watch & Learn
Browse All
A Patient's Story
DrB's Educational Presentations
Non-Preserved Eye Drop Safety
Regener-Eyes
StimulEyes
Sludge ™
The Placebo Effect
FDA Compliance
On Label, Off Label or No Label?
Placentas from Strangers
History
DEF Open Letter to Key Opinion Leaders (Nov 7, 2024)
FDA Warning Letter to Regenerative Processing Plant (Aug 16, 2024)
FDA Warning Letter to Neobiosis (June 5, 2024)
FDA Inspection Form 483 - RPP Tampa (June 23, 2023)
FDA Inspection Form 483 - RPP Palm Harbor (June 30, 2023)
DEF Open Letter to the FDA (May 12, 2023)
DEF Open Letter to the Eye Care Press (May 5, 2023)
DEF Open Letter to ABB Optical and Dry Eye Rescue (May 1, 2023)
FDA Public Safety Notification on Amniotic Fluid Eyedrops (Apr 10, 2023)
DEF Open Letter re StimulEyes (Mar 9, 2023)
DEF Open Letter to Regener-Eyes (Mar 5, 2023)
FDA Untitled Letter re StimulEyes (Nov 17, 2022)
FDA Untitled Letter to Regener-Eyes (Oct 5, 2022)
DEF Open Letter to Regener-Eyes (Sep 29, 2022)
DEF Regulatory Compliance Summary Information (June 8, 2022)
DEF Open letter for Eye Care Professionals (May 16, 2022)
Biologic Eye Drops
Home
FAQ
FAQ
Report problems to the FDA
Report deceptive advertising
Watch & Learn
Browse All
A Patient's Story
DrB's Educational Presentations
Non-Preserved Eye Drop Safety
Regener-Eyes
StimulEyes
Sludge ™
The Placebo Effect
FDA Compliance
On Label, Off Label or No Label?
Placentas from Strangers
History
DEF Open Letter to Key Opinion Leaders (Nov 7, 2024)
FDA Warning Letter to Regenerative Processing Plant (Aug 16, 2024)
FDA Warning Letter to Neobiosis (June 5, 2024)
FDA Inspection Form 483 - RPP Tampa (June 23, 2023)
FDA Inspection Form 483 - RPP Palm Harbor (June 30, 2023)
DEF Open Letter to the FDA (May 12, 2023)
DEF Open Letter to the Eye Care Press (May 5, 2023)
DEF Open Letter to ABB Optical and Dry Eye Rescue (May 1, 2023)
FDA Public Safety Notification on Amniotic Fluid Eyedrops (Apr 10, 2023)
DEF Open Letter re StimulEyes (Mar 9, 2023)
DEF Open Letter to Regener-Eyes (Mar 5, 2023)
FDA Untitled Letter re StimulEyes (Nov 17, 2022)
FDA Untitled Letter to Regener-Eyes (Oct 5, 2022)
DEF Open Letter to Regener-Eyes (Sep 29, 2022)
DEF Regulatory Compliance Summary Information (June 8, 2022)
DEF Open letter for Eye Care Professionals (May 16, 2022)
Home
Folder: FAQ
Back
FAQ
Report problems to the FDA
Report deceptive advertising
Folder: Watch & Learn
Back
Browse All
A Patient's Story
DrB's Educational Presentations
Non-Preserved Eye Drop Safety
Regener-Eyes
StimulEyes
Sludge ™
The Placebo Effect
FDA Compliance
On Label, Off Label or No Label?
Placentas from Strangers
Folder: History
Back
DEF Open Letter to Key Opinion Leaders (Nov 7, 2024)
FDA Warning Letter to Regenerative Processing Plant (Aug 16, 2024)
FDA Warning Letter to Neobiosis (June 5, 2024)
FDA Inspection Form 483 - RPP Tampa (June 23, 2023)
FDA Inspection Form 483 - RPP Palm Harbor (June 30, 2023)
DEF Open Letter to the FDA (May 12, 2023)
DEF Open Letter to the Eye Care Press (May 5, 2023)
DEF Open Letter to ABB Optical and Dry Eye Rescue (May 1, 2023)
FDA Public Safety Notification on Amniotic Fluid Eyedrops (Apr 10, 2023)
DEF Open Letter re StimulEyes (Mar 9, 2023)
DEF Open Letter to Regener-Eyes (Mar 5, 2023)
FDA Untitled Letter re StimulEyes (Nov 17, 2022)
FDA Untitled Letter to Regener-Eyes (Oct 5, 2022)
DEF Open Letter to Regener-Eyes (Sep 29, 2022)
DEF Regulatory Compliance Summary Information (June 8, 2022)
DEF Open letter for Eye Care Professionals (May 16, 2022)
Sludge™
DrB's Educational Presentations Rebecca Petris 7/31/22 DrB's Educational Presentations Rebecca Petris 7/31/22

Sludge™

The highly advertised contents of biologic eye drops - i.e. growth factors and cytokines - are very sensitive to their environment and require tightly controlled conditions to maintain stability. What happens when you fail to provide that environment?

Read More
The FDA and Autologous Serum Tears
DrB's Educational Presentations Rebecca Petris 7/31/22 DrB's Educational Presentations Rebecca Petris 7/31/22

The FDA and Autologous Serum Tears

Have you been told that Biologic Eye Drops (or “BED”, made from placenta or amniotic fluid) are similar to autologous serum tears (AST)? Watch this video to understand why they are actually vastly different from the standpoint of the FDA.

Read More
FDA Drug Approval for Biologic Eye Drops, Part 2 - Somewhat Less than the Whole Truth
DrB's Educational Presentations Rebecca Petris 7/14/22 DrB's Educational Presentations Rebecca Petris 7/14/22

FDA Drug Approval for Biologic Eye Drops, Part 2 - Somewhat Less than the Whole Truth

How biologic eye drop manufacturers confuse everyone using the Code of Federal Regulations - from HCT/P to PHS Section 361

Read More
FDA Drug Approval for Biologic Eye Drops, Part 1 - No Shortcuts Allowed
DrB's Educational Presentations Rebecca Petris 7/14/22 DrB's Educational Presentations Rebecca Petris 7/14/22

FDA Drug Approval for Biologic Eye Drops, Part 1 - No Shortcuts Allowed

How new drugs are approved, including biologics, and where currently marketed biologic eye drops stand.

Read More
Diagnosing Scam Pharma, Part 2 - The Astonishing New Regener-Eyes Advertisement
DrB's Educational Presentations Rebecca Petris 7/14/22 DrB's Educational Presentations Rebecca Petris 7/14/22

Diagnosing Scam Pharma, Part 2 - The Astonishing New Regener-Eyes Advertisement

Read More
Diagnosing Scam Pharma, Part 1 - The Facebook Photos Biopsy
DrB's Educational Presentations Rebecca Petris 6/27/22 DrB's Educational Presentations Rebecca Petris 6/27/22

Diagnosing Scam Pharma, Part 1 - The Facebook Photos Biopsy

The Facebook Photos Biopsy. Seven telltale ad features.

Read More
Placentas from Strangers, Part 2 -  Biological Eye Drops, Doctors & Scam Pharma
DrB's Educational Presentations Rebecca Petris 6/13/22 DrB's Educational Presentations Rebecca Petris 6/13/22

Placentas from Strangers, Part 2 - Biological Eye Drops, Doctors & Scam Pharma

Real pharma, scam pharma, what the FDA means by “illegal”, and why it can be hard even for good doctors to identify scam pharma.

Read More
On Label, Off Label, No Label, Part 2
DrB's Educational Presentations Rebecca Petris 6/9/22 DrB's Educational Presentations Rebecca Petris 6/9/22

On Label, Off Label, No Label, Part 2

What are the safety implications of moving past drugs whose adverse effects have been documented through clinical trials?

Read More
On Label, Off Label, No Label, Part 1 - How Radical Is Your Doctor?
DrB's Educational Presentations Rebecca Petris 6/5/22 DrB's Educational Presentations Rebecca Petris 6/5/22

On Label, Off Label, No Label, Part 1 - How Radical Is Your Doctor?

The difference between a not-approved drug and an unapproved use of an approved drug.

Read More
Placentas from Strangers, Part 1 - Dry Eye Patients & Scam Pharma
DrB's Educational Presentations Rebecca Petris 6/2/22 DrB's Educational Presentations Rebecca Petris 6/2/22

Placentas from Strangers, Part 1 - Dry Eye Patients & Scam Pharma

What do biologic eye drops have in common with a mocha frappuccino? What’s the difference between real pharma and scam pharma?

Read More
Biologic Eye Drops: Clearing Up Misconceptions
DrB's Educational Presentations Rebecca Petris 5/24/22 DrB's Educational Presentations Rebecca Petris 5/24/22

Biologic Eye Drops: Clearing Up Misconceptions

Have you been told that placenta or amniotic eye drops don’t require FDA approval? It’s time to clear up these misconceptions. DrB debunks five myths about biologic eye drops. (Related quick read: Fiction, Fantasy, Fib or Fact?)

Read More
Preservative-free eye drops and bacterial contamination
DrB's Educational Presentations Rebecca Petris 5/12/22 DrB's Educational Presentations Rebecca Petris 5/12/22

Preservative-free eye drops and bacterial contamination

What’s a Frankenstein bottle? How is bacterial contamination avoided in preservative-free eye drops? - Please don’t drip bacteria on your eye!

Read More
Newer Posts

About

Contact

Join Dry Eye Foundation mailing list(s)

Copyright © 2025. All rights reserved.